Peripheral CEA-Specific T-Cell Changes Predict Colorectal Cancer Immunotherapy Outcomes
A peripheral blood ELISpot assay quantifying CEA-specific T-cell responses predicts treatment response and progression-free survival in colorectal cancer patients receiving ...

